Track the 株式会社リボミック share price and the full insider trade history of the company, a listed issuer based in Japan. Shares are listed on JP JP, under the supervision of EDINET (Japan FSA). Market capitalisation: €4.2bn. The latest transaction was disclosed on 22 June 2026 (Holding update). Among the most active insiders: Evo Fund. All data is openly available.
25
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
18Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Ribomic Inc. is a Japanese company listed on the XTKS market, specializing in the development of drugs based on ribozyme technology. It focuses on innovative treatments for various diseases.